SOLV * Stock Overview
A healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Solventum Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1,400.00 |
| 52 Week High | US$1,485.00 |
| 52 Week Low | US$800.00 |
| Beta | 0 |
| 11 Month Change | 7.69% |
| 3 Month Change | 27.04% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 35.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| SOLV * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how SOLV * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how SOLV * performed against the MX Market.
Price Volatility
| SOLV * volatility | |
|---|---|
| SOLV * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: SOLV *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine SOLV *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | 22,000 | Bryan Hanson | www.solventum.com |
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.
Solventum Corporation Fundamentals Summary
| SOLV * fundamental statistics | |
|---|---|
| Market cap | Mex$237.68b |
| Earnings (TTM) | Mex$14.68b |
| Revenue (TTM) | Mex$167.49b |
16.2x
P/E Ratio1.4x
P/S RatioIs SOLV * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOLV * income statement (TTM) | |
|---|---|
| Revenue | US$8.22b |
| Cost of Revenue | US$3.58b |
| Gross Profit | US$4.63b |
| Other Expenses | US$3.91b |
| Earnings | US$720.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.17 |
| Gross Margin | 56.38% |
| Net Profit Margin | 8.76% |
| Debt/Equity Ratio | 254.0% |
How did SOLV * perform over the long term?
See historical performance and comparison